INTERNATIONAL PATENT: NANJING HUANBO BIOTECHNOLOGY CO., LTD. FILES APPLICATION FOR "USE OF A G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUND IN LOWERING BLOOD GLUCOSE, STIMULATING OR INCREASING INSULIN SECRETION, OR PREVENTING OR TREATING A DISEASE OR DISORDER RELATED THERETO"

GENEVA, Feb. 16 -- NANJING HUANBO BIOTECHNOLOGY CO., LTD. (No. 266 Puyun RoadNanjing, Jiangsu 210000) filed a patent application (PCT/CN2025/113611) for "USE OF A G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUND IN LOWERING BLOOD GLUCOSE, STIMULATING OR INCREASING INSULIN SECRETION, OR PREVENTING OR TREATING A DISEASE OR DISORDER RELATED THERETO" on Aug 08, 2025. With publication no. WO/2026/032430, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Zuling (No. 266 Puyun RoadNanjing, Jiangsu 210000), CAI, ...